“…Additionally, the activity of 1,2,3-triazole-containing dibenzo [b, e][1,4]diazepin-11-one hybrid 83 (IC 50 : 0.71 μm, MTT assay) against A549 cells is much higher than that of 5fluorouracil (IC 50 : 3.47 μm), and this hybrid could induce the G2/M phase of cell cycle arrest and apoptosis, indicating that hybrid 83 could be used for further studies as anti-lung cancer candidates (Praveen Kumar et al, 2016). Some other compounds which are combined by 1,2,3-triazole and benzodiazepine/benzoxepine/dithiocarbamate/ deoxysalinomycin/myrrhanone B /phenanthrene/pyrano(2,3-c) phenazine/paeonol/naphthalimide/sesquiterpene/sulfonate ester/sapinofuranone/triterpene/thiourea/benzothiazinone/ benzoxazinone/furan/nimesulide (Kuntala et al, 2015;Poornima et al, 2015;Sudhapriya et al, 2015;Chandrashekhar et al, 2016;Reddy et al, 2016;Shaikh et al, 2016;Abdallah et al, 2017;Battula et al, 2017;Kumar et al, 2017;Lu et al, 2017;Mareddy et al, 2017;Mo et al, 2017;Nguyen et al, 2017;Narsimha et al, 2018;Ou et al, 2019;Yang et al, 2019;Jiang et al, 2020;Kanabar et al, 2020;Madasu et al, 2020;Qi et al, 2020;) also possess certain activity against lung cancer cell lines, but their activities are generally far inferior to those of the references. Hence, these derivatives still need further structural modifications.…”